Can Dolutegravir Tablets Be Crushed?
Yes, dolutegravir tablets can be crushed for patients with swallowing difficulties, though this practice increases dolutegravir exposure by approximately 26-30% compared to whole tablets. 1
Key Evidence from FDA Labeling
The FDA label for TIVICAY PD (dolutegravir pediatric dispersible formulation) explicitly states that tablets for oral suspension may be swallowed whole or dispersed in drinking water and should not be chewed, cut or crushed 2. However, this guidance applies specifically to the dispersible formulation, not the standard film-coated tablets.
Importantly, the FDA label emphasizes that TIVICAY and TIVICAY PD are not bioequivalent and are not interchangeable on a milligram-per-milligram basis 2. This distinction is critical when considering crushing standard tablets.
Clinical Research Evidence
A well-designed 2018 crossover trial in 22 healthy volunteers directly addressed this question 1:
- Crushing standard dolutegravir fixed-dose combination tablets (Triumeq®) resulted in:
- 26% higher AUC (total drug exposure)
- 30% higher Cmax (peak concentration)
- These increases did NOT exceed exposures seen with food intake or twice-daily dosing
The study authors concluded that Triumeq can be crushed for patients with swallowing difficulties and can be simultaneously administered with enteral nutrition 1.
Real-World Clinical Experience
A 2023 retrospective review of ICU patients unable to take medications by mouth demonstrated:
- 56.6% experienced only transient therapy interruptions
- Most patients maintained or achieved viral suppression when dolutegravir/bictegravir regimens were crushed 3
This real-world data supports the safety and efficacy of crushing dolutegravir in clinical practice.
Practical Considerations
When Crushing Is Appropriate:
- Patients with dysphagia or swallowing difficulties
- Unconscious patients requiring enteral administration
- ICU patients unable to take oral medications
Safety Profile:
The 26-30% increase in dolutegravir exposure from crushing remains within safe limits because:
- It does not exceed exposure from taking dolutegravir with food (which is recommended)
- It remains below exposure from twice-daily dosing (50 mg BID), which is safely used with rifampin 4
- No increased toxicity was observed in clinical studies 1
Important Caveats:
- Do NOT crush TIVICAY PD dispersible tablets - these should be dispersed whole in water 2
- Verify you have the correct formulation before crushing (standard film-coated tablets vs. dispersible tablets) 2
- Monitor viral load more closely after initiating crushed administration, particularly in the first 1-3 months
- Document the crushing practice and rationale in the medical record
Administration Technique
When crushing is necessary:
- Crush the tablet completely to a fine powder
- Can be mixed with small amounts of water or enteral nutrition
- Administer immediately after preparation
- Flush feeding tubes adequately to ensure complete dose delivery
The evidence supports that crushing standard dolutegravir film-coated tablets is a viable option for patients who cannot swallow whole tablets, with maintained virological efficacy despite modestly increased drug exposure 1, 3.